ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
03/02/201517:30:14Salix Posts Loss Amid Push to Clear Inventory
02/23/201517:04:20U.S. Stocks Decline, Mirroring Oil's Resumed Drop
02/23/201517:00:34MARKET SNAPSHOT: Dow, S&P Slump; Nasdaq Marks 9-session Win Streak
02/23/201515:52:37MARKET SNAPSHOT: Stocks Retreat From Records As Oil Drop Hits...
02/23/201513:39:04MARKET SNAPSHOT: U.S. Stocks Give Up Records As Oil Drop Hits...
02/23/201513:33:18MARKET SNAPSHOT: U.S. Stocks Slide As Oil Drop Hits Energy Companies
02/23/201513:29:14MARKET SNAPSHOT: U.S. Stocks: Futures Dip As Oil Slide Hits Energy...
02/23/201513:17:27MARKET SNAPSHOT: U.S. Stocks: Futures Dip Ahead Of Home Sales...
02/23/201511:03:56MARKET SNAPSHOT: U.S. Stocks: Futures Dip Ahead Of Home Sales...
02/22/201517:20:08Valeant Pharmaceuticals to Buy Salix for About $10 Billion...
02/22/201517:05:14Valeant Pharmaceuticals to Buy Salix for About $10 Billion...
02/22/201516:52:15Valeant Pharmaceuticals to Buy Salix for About $10 Billion
02/21/201517:02:14Valeant Nears Deal to Buy Salix
02/20/201514:57:21Valeant Approved to Buy Dendreon Assets for $495 Million

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad